| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/19/2011 | CN101947262A Traditional Chinese medicinal externally-applied tincture for treating tinea pedis |
| 01/19/2011 | CN101947253A External compound preparation for curing tinea corporis as well as preparation method and content measuring method thereof |
| 01/19/2011 | CN101947244A Disinfection pill |
| 01/19/2011 | CN101947243A Mushroom poison paste |
| 01/19/2011 | CN101947239A Drug for treating psoriasis |
| 01/19/2011 | CN101947215A Application of flavonoid compound in tangerine peel to preparation of medicament for inhibiting angiogenesis |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101543477B Sustained-release microsphere of chitosan-coated 3,5-dihydroxy-4-isopropyl toluylene and preparation method thereof |
| 01/19/2011 | CN101536997B Application of ginseng alkynol in pharmacy |
| 01/19/2011 | CN101401853B Medicament composition for treating burn, scald and preparation method thereof |
| 01/19/2011 | CN101385775B Medicine for treating tinea pedis and preparation method thereof |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101244131B Medicament for treating skin trauma and muscle trauma type ulcer |
| 01/19/2011 | CN101239134B Speckle-removing medicinal composition |
| 01/19/2011 | CN101239077B Chinese medicine for treating skin disease |
| 01/19/2011 | CN101209257B Medical use of baicalin and scutellarein derivatives |
| 01/19/2011 | CN101181421B Chinese medicine for curing corn |
| 01/19/2011 | CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872098 derivatives of peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY pharmaceutical compositions; capable of stimulating in vitro the proliferation and the secretion of IL-2 by the CD4+ T cells purified from the ganglia |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7872052 2-(2-iodophenyl)-6,7-dimethoxybenzo[d][1,3]oxazin-4-one for treating atopic dermatitis, contact dermatitis, eczema, psoriasis, acne, epidermal hyperkeratosis, acanthosis, epidermal inflammation, dermal inflammation and pruritus |
| 01/18/2011 | US7872047 idebenone octanoate; idebenone conjugated linoleate, idebenone linoleate; dematology; skin roughness, skin wrinkles, photodamaged skin, skin hyperpigmentation, skin irritation and skin inflammatory reaction |
| 01/18/2011 | US7872029 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 01/18/2011 | US7872025 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871766 Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant Argania spinosa |
| 01/18/2011 | US7871635 comprising a cosmetically acceptable medium and a compound N-( omega -undecylenoyl) phenylalanine; inactivates adenylate cyclase and has an affinity for the melocytic specific hormone ( alpha -MSH) |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | US7871599 shampoo or conditioner suitable for topical application in style hair and in particular to lengthening, reducing the volume and increasing the high humidity style retention of the hair |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2475630C N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 01/18/2011 | CA2440472C Methods of treating acne |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/13/2011 | WO2011005660A1 Tofa analogs useful in treating dermatological disorders or conditions |
| 01/13/2011 | WO2011005406A2 Skin repair compositions comprising circadian gene activators and a synergistic combination of sirt1 gene activators |
| 01/13/2011 | WO2011005380A2 Arg-gly-asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 01/13/2011 | WO2011005290A1 Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2011003236A1 The preparation and uses of a longan seed extract |
| 01/13/2011 | WO2011003172A1 Controlled nitric oxide delivery from aqueous s-nitrosothiol conjugated polymers and their complexes |
| 01/13/2011 | WO2010107794A3 Compositions and methods for delivering an agent to a wound |
| 01/13/2011 | WO2010077101A4 Novel thiazolidinedione derivative and use thereof |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009489 Cosmetic composition comprising vitamin u as active ingredient for healing wounds and reducing wrinkles |
| 01/13/2011 | US20110009486 Method for treating pruritus by administering fullerenes |
| 01/13/2011 | US20110009483 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 01/13/2011 | US20110009481 Medicament for the treatment of viral skin and tumour diseases |
| 01/13/2011 | US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009470 Nucleic acid external skin formulation |
| 01/13/2011 | US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009444 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009439 Indene derivatives as pharmaceutical agents |
| 01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009393 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009374 Method of wound healing and scar modulation |
| 01/13/2011 | US20110009365 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009334 System and method for inhibiting cellular proliferation with tachykinins |
| 01/13/2011 | US20110009333 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 01/13/2011 | US20110009332 Therapeutic Treatment Of Wounds |
| 01/13/2011 | US20110009316 Proteolysis resistant active vegf |
| 01/13/2011 | US20110009310 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation |
| 01/13/2011 | US20110008458 Process for removing growth factors from platelets |
| 01/13/2011 | US20110008455 Crosslinked Protein Nanocrystals, Crosslinked Protein Nanoaggregates and Method of Preparation Thereof |
| 01/13/2011 | US20110008453 Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof |
| 01/13/2011 | US20110008445 Suspension of ascorbic acid in glycerin and process for production thereof |
| 01/13/2011 | US20110008420 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/13/2011 | US20110008411 Method of treating pruritis |
| 01/13/2011 | US20110008404 Modification Of Biomaterials With Microgel Films |
| 01/13/2011 | US20110008394 Active substances that increase the activation threshold of immune cells |
| 01/13/2011 | US20110008366 Inhibition of versican with sirna and other molecules |
| 01/13/2011 | US20110008365 Methods of treating scleroderma |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008340 Anti-properdin antibodies |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008326 Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008312 Radical therapeutic agent for keloid and hypertrophic scar |
| 01/13/2011 | US20110008308 Composition for hair, skin, nails |
| 01/13/2011 | US20110008306 Creatine-ligand compounds and methods of use thereof |
| 01/13/2011 | US20110008305 Nano-emulsion composition of coenzyme q10 |